GSK: ViiV Healthcare Gets FDA Approval For HIV Treatment Cabenuva – Quick Facts

This post was originally published on this site

(RTTNews) – GlaxoSmithKline plc (GSK, GSK.L) said Friday that its majority-owned specialist HIV company ViiV Healthcare has received approval from the US Food and Drug Administration for Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for the treatment of HIV-1 infection in adults.

Cabenuva is provided as a…

Bastion Balance Seoul, Korea.